Table 3.
Comparing femal vs male cases with skin tumors regarding site and character of the tumor.
| Females n=24 | Males n=70 | Total | |
|---|---|---|---|
| Primary vs. Secondary | |||
| Primary | 23 (95.8%) | 66 (94.3%) | 89 (94.7%) |
| Secondary | 1 (4.2%) | 4 (5.7%) | 5 (5.3%) |
| Site | |||
| Extremities | 3 (12.5%) | 16 (22.9%) | 19 (20.2%) |
| Head & Neck | 17 (70.8%) | 41 (58.6%) | 58 (61.7%) |
| Trunk | 4 (16.7%) | 13 (18.6%) | 17 (18.1%) |
| Pathology | |||
| BCC | 16 (66.7%) | 39 (55.7%) | 55 (58.5%) |
| SCC | 5 (20.8%) | 12 (17.1%) | 17 (18.1%) |
| MM | 1 (4.2%) | 10 (14.3%) | 11 (11.7%) |
| DFSP | 1 (4.2%) | 3 (4.3%) | 4 (4.3%) |
| Secondary Lymphoma | 1 (4.2%) | 2 (2.9%) | 3 (3.2%) |
| Sebaceous Carcinoma | 0 (.0%) | 2 (2.9%) | 2 (2.1%) |
| Secondary Cancer Lung (small cell) | 0 (.0%) | 1 (1.4%) | 1 (1.1%) |
| Secondary Cancer Stomach (Adenocarcinoma) | 0 (.0%) | 1 (1.4%) | 1 (1.1%) |